These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 4593769)
1. The effect of spironolactone on antipyrine metabolism in man. Huffman DH; Shoeman DW; Pentikäinen P; Azarnoff DL Pharmacology; 1973; 10(6):338-44. PubMed ID: 4593769 [No Abstract] [Full Text] [Related]
2. Effect of spironolactone on antipyrine metabolism in calves. Janus K; Suszycka J Res Vet Sci; 1996 Jul; 61(1):87-8. PubMed ID: 8819201 [TBL] [Abstract][Full Text] [Related]
3. The effect of combined pre-treatment on the metabolism of antipyrine in the rat. Szabó I; Renczes G; Gachályi B Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837 [TBL] [Abstract][Full Text] [Related]
4. Effect of phenobarbital and spironolactone treatment on the oxidative metabolism of antipyrine by rat liver microsomes. Szakács T; Veres Z; Vereczkey L Pol J Pharmacol; 2001; 53(1):11-9. PubMed ID: 11785906 [TBL] [Abstract][Full Text] [Related]
5. Antipyrine metabolism in man. Kellermann GH; Luyten-Kellermann M Life Sci; 1978 Dec; 23(25):2485-90. PubMed ID: 732536 [No Abstract] [Full Text] [Related]
6. Spironolactone--a weak enzyme inducer in man. Taylor SA; Rawlins MD; Smith SE J Pharm Pharmacol; 1972 Jul; 24(7):578-9. PubMed ID: 4403853 [No Abstract] [Full Text] [Related]
7. Antipyrine metabolite kinetics in rats: studies on dose and time dependence. Rhodes JC; Houston JB Biopharm Drug Dispos; 1983; 4(2):125-35. PubMed ID: 6411138 [TBL] [Abstract][Full Text] [Related]
8. Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation. Danhof M; Idle JR; Teunissen MW; Sloan TP; Breimer DD; Smith RL Pharmacology; 1981; 22(6):349-58. PubMed ID: 7267701 [TBL] [Abstract][Full Text] [Related]
9. Dose-dependent pharmacokinetics of antipyrine in the rat. Pollack GM; Li RC; Shen DD Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251 [TBL] [Abstract][Full Text] [Related]
10. [Enhanced drug hydroxylation in man under diphenyl-hydantoin therapy]. Petruch F; Schüppel RV Arzneimittelforschung; 1974 Jul; 24(7):1023-5. PubMed ID: 4211429 [No Abstract] [Full Text] [Related]
12. Haem biosynthesis and hydroxylation of phenazone during lead intoxication. Campbell BC; Meredith PA; Moore MR; Brodie MJ; Thompson GG; Goldberg A Biochem Soc Trans; 1976; 4(6):1088-9. PubMed ID: 1022564 [No Abstract] [Full Text] [Related]
13. [Influence of ranitidine on antipyrine metabolism (author's transl)]. Staiger C; Simon B; de Vries J; Kather H; Walter E Z Gastroenterol; 1980 Dec; 18(12):601-4. PubMed ID: 6116365 [TBL] [Abstract][Full Text] [Related]
14. Antipyrine pharmacokinetics in the pregnant rat. Dean M; O'Donnell L; Penglis S; Stock B Drug Metab Dispos; 1980; 8(4):265-7. PubMed ID: 6105062 [TBL] [Abstract][Full Text] [Related]
15. Effect of alphamethyldopa on the half-lives of antipyrine, tolbutamide and D-glucaric acid excretion in man. Gachályi B; Tornyossy M; Vas A; Káldor A Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):133-5. PubMed ID: 6103880 [TBL] [Abstract][Full Text] [Related]
16. On the regulation of antipyrine and oxazepam metabolism in man. Kellermann GH; Luyten-Kellermann M Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954 [TBL] [Abstract][Full Text] [Related]
18. Effects of urea on hexobarbital and antipyrine disposition in rats. Valentovic M; Bachmann K Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718 [TBL] [Abstract][Full Text] [Related]
19. Ketoconazole does not impair antipyrine clearance in humans. Blyden GT; Abernethy DR; Greenblatt DJ Int J Clin Pharmacol Ther Toxicol; 1986 May; 24(5):225-6. PubMed ID: 3733272 [TBL] [Abstract][Full Text] [Related]
20. [Metabolism of antipyrine in man]. Pautet F; Barret R; Daudon M; Mathian B Pathol Biol (Paris); 1985 Sep; 33(7):777-80. PubMed ID: 3909077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]